Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human gut metagenome

ABSTRACT: Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome

PROVIDER: PRJNA311208 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3160450_1.fastq.gz	Fastqsanger.gz
	SRR3160450_2.fastq.gz	Fastqsanger.gz
	SRR3160460_1.fastq.gz	Fastqsanger.gz
	SRR3160460_2.fastq.gz	Fastqsanger.gz
	SRR3160441_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

Project description:EMG produced TPA metagenomics assembly of the Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome (human gut metagenome) data set.

| PRJEB26833 | ENA

human gut metagenome

Project description:Microbiota in short bowel syndrome

| PRJNA309478 | ENA

Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice

Project description:Gut dysbiosis is closely involved in the pathogenesis of inflammatory bowel disease (IBD). However, it remains unclear whether IBD-associated gut dysbiosis plays a primary role in disease manifestation or is merely secondary to intestinal inflammation. Here, we established a humanized gnotobiotic (hGB) mouse system to assess the functional role of gut dysbiosis associated with two types of IBD - Crohn's disease (CD) and ulcerative colitis (UC). In order to explore the functional impact of dysbiotic microbiota in IBD patients on host immune responses, we analyzed gene expression profiles in colonic mucosa of hGB mice colonized with healty (HC), CD, and UC microbiota.

2015-10-10 | GSE73882 | GEO

human gut metagenome

Project description:Gut microbiota in short bowel syndrome

| PRJDB4453 | ENA

Gut microbiome dynamics in short bowel syndrome mice

Project description:Gut microbiome dynamics in short bowel syndrome mice

| PRJEB52226 | ENA

Project description:Fecal microbiome in pediatric patients with short bowel syndrome

| PRJNA754038 | ENA

human gut metagenome

Project description:gut microbiota in patients with irritable bowel syndrome

| PRJNA563780 | ENA

Short bowel syndrome mouse microbiome

Project description:Short bowel syndrome mouse microbiome

| PRJEB26648 | ENA

Opioid-induced gut microbial disruption leads to gut barrier compromise and sustained systemic inflammation.

Project description:Morphine and its pharmacological derivatives are the most prescribed analgesics for moderate to severe pain management. However, chronic use of morphine reduces pathogen clearance and induces bacterial translocation across the gut barrier. The enteric microbiome has been shown to play a critical role in the preservation of the mucosal barrier function and metabolic homeostasis. Here, we show for the first time, using bacterial 16s rDNA sequencing, that chronic morphine treatment significantly alters the gut microbial composition and induces preferential expansion of the gram-positive pathogenic and reduction of bile-deconjugating bacterial strains. A significant reduction in both primary and secondary bile acid levels was seen in the gut, but not in the liver with morphine treatment. Morphine induced microbial dysbiosis and gut barrier disruption was rescued by transplanting placebo-treated microbiota into morphine-treated animals, indicating that microbiome modulation could be exploited as a therapeutic strategy for patients using morphine for pain management. In this study, we establish a link between the two phenomena, namely gut barrier compromise and dysregulated bile acid metabolism. We show for the first time that morphine fosters significant gut microbial dysbiosis and disrupts cholesterol/bile acid metabolism. Changes in the gut microbial composition is strongly correlated to disruption in host inflammatory homeostasis13,14 and in many diseases (e.g. cancer/HIV infection), persistent inflammation is known to aid and promote the progression of the primary morbidity. We show here that chronic morphine, gut microbial dysbiosis, disruption of cholesterol/bile acid metabolism and gut inflammation; have a linear correlation. This opens up the prospect of devising minimally invasive adjunct treatment strategies involving microbiome and bile acid modulation and thus bringing down morphine-mediated inflammation in the host.

2016-06-01 | E-MTAB-3722 | biostudies-arrayexpress

rat gut metagenome

Project description:Studies of microbial sequencing of a rat short bowel syndrome model.

| PRJDB9356 | ENA